Follicum

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Finance

Follicum appoints Jonas Edelswärd as CFO

During the period July 2018 to June 2019, he was a board member of Follicum
Finance

Follicum appoints CEO and establishes Chief Scientific Officer role

Current CEO Jan Alenfall will, for a period of at least six months continue to work in the company in the position of Chief Scientific Officer
Regulatory

Follicum obtains US patent for peptides

The patent will be formally approved on October 27, 2020
Pharmaceutical

Follicum selects new diabetes drug candidate

New peptide drug candidate that protect beta cells and address other diabetes complications to enter preclinical stages
Ingredients

Follicum teams up with University of Bradford on peptide research

Follicum signs agreement with Centre for Skin Sciences at University of Bradford for mode of action studies
Research & Development

Follicum expands patent portfolio

First diabetes patent published and promising experimental data supports new patent application
Research & Development

Follicum identifies receptors for potential new class of diabetes drug

This represents an important milestone in the continued development of Follicum's diabetes drug project, opening the possibility of the identified receptors becoming a potential drug target for stimulating insulin secretion and reducing diabetic complications
Subscribe now